Douglas Ney, MD

Professional Titles

• Professor of Neurology and Neurosurgery
• Program Director, Neurology Residency Program
• Vice-Chair Education, Department of Neurology

Publications

• Ney, DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE. Characteristics and Outcomes of Elderly Patients with Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Experience. Cancer. 2010 Oct 1;116(19):4605-12.
• Ney DE, Huse JT, Dunkel IJ, Steinherz PG, Haque S, Khakoo Y. Intraventricular Meningioma after Cranial Radiation for Childhood Leukemia. J Child Neurol. 2010 Oct;25(10):1292-5.
• Ney, DE, Lassman AB. Brain Tumors in Adults. In Conn’s Current Therapy 2011, 63nd edition. Eds. R. Rakel and E. Bope. Saunders Elsevier Science, Philadelphia, PA. 2011.
• Clarke J, Ney DE, Shyu C, Lassman AB. Supratentorial Gliomas. In Principles and Practices of Neuro-Oncology: A Multidisciplinary Approach. Mehta, Chang, Vogelbaum, Guha, et al. editors. Demos Publishing, 2010.
• Ney, DE, Lassman AB. Brain Tumors in Adults. In Conn’s Current Therapy 2012, 64th edition. Eds. R. Rakel and E. Bope. Saunders Elsevier Science, Philadelphia, PA. 2012.
• Hilary S Serracino, Adam Khalil, Denise Damek, Douglas Ney, Kevin O Lillehei, Bette K Kleinschmidt-DeMasters.Gliomas Arising in Patients with Multiple Sclerosis Have No Distinctive Genetic Features. 2012 United States & Canadian Academy of Pathology Meeting (USCAP). Vancouver, BC. March 17-23, 2012.
• Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys. 2012 Apr 5.
• Khalil A, Serracino H, Damek DM, Ney D, Lillehei KO, Kleinschmidt-Demasters BK. Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neurooncol. 2012 May 1.
• Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
• Ney DE, Messersmith W, Behbakht K. Anti-Ma2 paraneoplastic encephalitis in association with recurrent cervical cancer. J Clin Neuro (accepted 4/13).
• Sarah Clark, Julie A. Carlson, Laurie E. Gaspar, Douglas E. Ney, Changhu Chen, Brian Kavanagh, Denise M. Damek. Meningioma WHO Grade II-III: Temozolomide with and without radiation in the management of WHO Grade II and III meningiomas. The 17th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO), Washington, D.C. November 15-18, 2012
• Denise M. Damek, Douglas E. Ney, Manuel T. Borges, William Colantoni, Robert Bert. Arterial spin labeling perfusion and dynamic susceptibility contrast perfusion MRI in posttreatment malignant glioma evaluation. The 17th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO), Washington, D.C. November 15-18, 2012
• Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2014 Dec 19. [Epub ahead of print] PubMed PMID: 25524817
• Ney DE, Messersmith W, Behbakht K. Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer. J Clin Neurol. 2014 Jul;10(3):262-6. PubMed PMID: 25045381
• Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
• Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Barón AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The Impact of Adjuvant Radiation Therapy for High-Grade Gliomas by Histology in the United States Population. International Journal of Radiation Oncology, Biology, Physics.
• Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar;122(1):135-43. PubMed PMID: 25524817
• Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun;123(2):251-7. PubMed PMID: 25920710
• Schowinsky J, Leppert M, Ney D, Kleinschmidt-DeMasters BK. Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides. J Neuropathol Exp Neurol. 2015 Oct;74(10):948-51. PubMed PMID: 26352990
• Romero M, González-Fontal GR, Saavedra C, Guerra J, Quintero G, Quijano S, Ney D, Henao-Martínez AF. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report. Diagn Cytopathol. 2016 Jan;44(1):61-5. PubMed PMID: 26468050
• Amini A, Atloos B, Karam S, Waxwelier T, Rusthoven C, Gaspar L, Honce J, Damek D, Ney D, Ormond D, Lillehei K, Chen C, Kavanagh B, Liu A. Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM). J Radiat Oncol. Oct 2015
• Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 Jul 1;73(7):821-8. PubMed PMID: 27214765
• Romero M, González-Fontal GR, Saavedra C, Guerra J, Quintero G, Quijano S, Ney D, Henao-Martínez AF. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report. Diagn Cytopathol. 2016 Jan;44(1):61-5. PubMed PMID: 26468050
• Bert RJ. Colantoni W, Ney DE, Damek DM, Kleinschmidt-DeMasters BK, Borges MT. Visual assessment for primary central nervous system tumor recurrence, progression or persistence: a comparison of arterial spin labeling and dynamic susceptibility contrast-enhanced MR perfusion techniques. International Journal of Radiology and Imaging Technology. Accepted: May 2016.
• Andrew Johnson, Zohra Nooruddin, Gentry King, Henning Schade, Manali Kamdar, Brad Haverkos, Douglas Ney. Single institution retrospective review of patients with primary CNS lymphoma (PCNSL). 2016 ASCO Annual Meeting. June 3-7, 2016. Chicago, Illinois.
• Zohra Nooruddin, Zenggang Pan, Lilyana Gross, David Weitzenkamp, Daniel Pollyea, Jonathan Gutman, William Robinson, Clayton Smith, Jeffrey Schowinsky, Bradley Haverkos, Enkhtsetseg Purev, Daniel Sherbenou, Rachel Rabinovitch, Douglas Ney, Craig Jordan, Manali Kamdar. Final results of the IHC analysis and prognostic factors in post transplant lymphoproliferative disorders after solid organ transplantation. 21st Congress of the European Hematology Association. June 9-12, 2016. Copenhagen, Denmark.
• Augusto Miravalle, Ralph Jozefowicz, Teri Schreiner, Doug Ney, Pearce Korb, Alan Anderson, Lauren Frey, Monica McNulty, Eva Aagaard. Development of a Validated Neurology Specific Rotaional EPAs for GME. The AAMC Annual Meeting. November 11-15, 2016. Seattle, Washington.
• Ung T, Ney D, Damek D, Yousseff S, Lillhehei K, Ormond D. Using the neurologic assessement in neuro-oncology (NANO) scale as a predictive assessment tool for survival in patients with primary glioblastoma. 21st Annual Society for Neuro-Oncology Annual Scientific Meeting and Education Day. November 17-20, 2016. Scottsdale, AZ.
• Alexander Mohler, Amy Callan, Renee Peter, Laura Palmer, Douglas Ney. Improving Patient Outcomes Through a Multidisciplinary Neuro-Oncology Rehabilitation Clinic. 21st Annual Society for Neuro-Oncology Annual Scientific Meeting and Education Day. November 17-20, 2016. Scottsdale, AZ.
• Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018 Jun;128(6):1713-1718. PubMed PMID: 28753117
• Nguyen GH, Mohler A, Leppert M, Parra C, Zeng YP, Prok L, Schowinsky J, Magro CM, Pacheco T, Ney D. Index Case of Cutaneous Follicular Mycosis Fungoides With Central Nervous System Involvement and Review of Literature. Am J Dermatopathol. 2018 Mar;40(3):185-190. PubMed PMID: 29470304
• Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-Oncology Quality Measurement Set. Neuro Oncol. 2018 Mar 27;20(4):531-537. PubMed PMID: 29509930
• Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-oncology quality measurement set. Neurology. 2018 Apr 3;90(14):652-658. PubMed PMID: 29500290
• Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2018 Mar 30. [Epub ahead of print] PubMed PMID: 29618103
• Khan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet AL. CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurol Clin Pract. 2019 Jun;9(3):273-276. PubMed PMID: 31341717
• Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ. Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging. Neurology. 2019 Jan 22;92(4):199-203. PubMed PMID: 30665912
• Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2019 Mar 1;84(3):687-695. PubMed PMID: 29618103
• Kluger BM, Ney DE, Bagley SJ, Mohile N, Taylor LP, Walbert T, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer. J Palliat Med. 2019 Oct 15. [Epub ahead of print] PubMed PMID: 31613698
• Daniel EB, Ney DE, Mulcahy Levy JM. MEK inhibition with trametinib is a successful therapy in ganglioglioma. Clinical Case Reports and Reviews. 2020, Volume 6; 1-2.
• Kapadia RK, Ney D. Stabilization of Progressive Multifocal Leukoencephalopathy After Pembrolizumab Treatment. Neurohospitalist. 2020 Jul;10(3):238-239. PubMed PMID: 32549952
• Kapadia RK, Ney DE, Hannan M, Farley M, Pastula DM, Piquet AL. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab. J Neuroimmunol. 2020 Jul 15;344:577259. PubMed PMID: 32416558
• Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu M. Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic. Neuro Oncol. 2020 Apr 11. [Epub ahead of print] PubMed PMID: 32277236
• Bert RJ, William C III, Ney DE, Damek DM, Kleinschmidt-DeMasters BK, Borges MT. Comparison of Arterial Spin Labeling and Dynamic Susceptibility Contrast-Enhanced MR Perfusion in Differentiating Tumor Recurrence from Treatment-Related changes. Int J Radiol Imaging Technol. 3:022. Feb 2017
• Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2017 Jul 28;:1-6. [Epub ahead of print] PubMed PMID: 28753117
• Fakhoury KR, Ney DE, Ormond DR, Rusthoven CG. Immunotherapy and radiation for high-grade glioma: a narrative review. Transl Cancer Res 2021;10(5):2537-2570.
• Wolf AB, Shiao JC, Rabinovitch RA, Schowinsky JT, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-term control of primary cerebral ALH amyloidoma with focal radiation therapy. Advances in radiation Oncology. Submitted April 2021.
• Mohile N, Messersmith H, Gatson N, Hottinger A, Lassman A, Morton J, Ney DE, et al. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors: ASCO-SNO Guidelines. J Clin Oncol. Submitted July 2021.
• Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim M, Reddy N, Ney DE, et al. EBV-positive primary CNS lymphomas in older patientsL incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Annals Oncology. Submitted August 2021
• Caroline Goldin and Douglas Ney. Primary Central Nervous System Lymphoma. Medscape Drugs and Diseases. Updated July 6, 2021.
• Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100831. PubMed PMID: 34934868
• Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 Feb 1;40(4):403-426. PubMed PMID: 34898238
• Fakhoury KR, Ney DE, Ormond DR, Rusthoven CG. Immunotherapy and radiation for high-grade glioma: a narrative review. Transl Cancer Res. 2021 May;10(5):2537-2570. PubMed PMID: 35116570
• Daniel EB, Ney DE, Levy JMM. MEK inhibition with trametinib is a successful therapy in ganglioglioma. Clin Case Rep Rev. 2020 Jun;6(2). PubMed PMID: 32999736
• Schindler SE, Ney DE, Goss AL, Rabinovici G. ANA Investigates: The Future of Biomarkers in Alzheimer Disease. Ann Neurol. 2022 Aug;92(2):159-160. PubMed PMID: 35689567
• Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 Feb 1;40(4):403-426. PubMed PMID: 34898238
• Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G. Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol. 2022 Sep 24. [Epub ahead of print] PubMed PMID: 36151879
• David KA, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Bond DA, Agrawal P, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Folstad M, Kumar P, Ollila TA, Cai J, Spurgeon S, Sieg A, Cleveland J, Chang J, Epperla N, Karmali R, Naik S, Martin P, Smith SM, Rubenstein J, Kahl B, Evens AM. Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers. Am J Hematol. 2023 Jun;98(6):900-912. PubMed PMID: 36965007
• Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Gandhi MK, Keane C, Bond DA, Folstad M, Chang J, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Matnani R, Kumar P, Ollila TA, Cai J, Spurgeon SE, Sieg AG, Cleveland J, Epperla N, Karmali R, Naik S, Smith SM, Rubenstein JL, Kahl BS, Chadburn A, Evens AM, Martin P. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023 May;64(5):1026-1034. PubMed PMID: 36960939
• Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. Ann Neurol. 2023 Feb;93(2):257-270. PubMed PMID: 36151879
• Danielle Wilhour, Samantha Holden, Katy Apologianis, Douglas Ney. Action Potential: Impact of Coaching on Wellbeing for Neurology Faculty and Trainees at the University of Colorado. 2024 Annual Meeting of the American Academy of Neurology. April 13-18, 2024. Denver, Colorado.

Professional Memberships

• Society Neuro-Oncology, Member
• American Society of Clinical Oncology, Member
• American Academy of Neurology, Member
• American Neurological Association, Member
• Association for University Professors of Neurology, Member

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Court, Anschutz Cancer Pavilion, 2nd Floor, Suite 2004
Aurora, CO 80045
720-848-0300

Hospital Affiliation

• University of Colorado Hospital

Center Affiliations

• University of Colorado Cancer Center

Specialty Information

Specialties

• Neurology, Board Certification (2008, 2018)
• Neuro-Oncology
• United Council of Neurologic Subspecialties Certification in Neuro-Oncology, Board Certification (2013)

Conditions & Treatments

• Brain and Nervous System - Brain Tumors
• Cancers - Brain Cancer
• Brain and Nervous System
• Cancers